S.K. Dinda et al. / Tetrahedron 66 (2010) 9304e9309
9309
1.07, MeOH). IR (KBr): 3387, 3322, 2920, 2362, 1339, 1173 cmꢁ1. 1H
NMR (200 MHz, CDCl3): 5.38e5.32 (m, 1H), 4.45e4.29 (m, 2H),
Anal. Calcd for C20H41N3O2: C, 67.56; H, 11.62; N, 11.82. Found: C,
67.71; H, 11.83; N, 12.02.
d
3.83e3.73 (m, 2H), 3.08 (s, 3H), 2.78 (d, 1H, J¼6.7), 1.85e1.13 (m,
28H), 0.88 (t, 3H, J¼6.6). 13C NMR (50 MHz, CDCl3):
d
72.5, 72.2, 71.0,
4.1.19. (2S,3S)-2-Aminooctadecan-3-ol (23). From 22 (95 mg,
0.27 mmol), the title compound was prepared in the same manner
as that described for 1 from 10. Purification of the crude product by
silica gel column chromatography (50% methanol in CHCl3) affor-
37.5, 32.7, 31.9, 31.8, 29.8, 29.6, 29.5, 29.4, 29.3, 29.2, 27.2, 25.7, 22.6,
14.1. MS (ESI): m/z 380 [M]þ, 403 [MþNa]þ. Anal. Calcd for
C19H40O5S: C, 59.96; H, 10.59. Found: C, 59.74; H, 9.87.
ded 23 (58 mg, 75%) as a white solid. Mp: 73e75 ꢀC. Rf: 0.48 (20%
25
4.1.15. (2R,3S)-1,2-Epoxyoctadecan-3-ol (19). A solution of com-
pound 18 (o.80 g, 2.1 mmol) in dry MeOH (30 mL) was treated with
K2CO3 (0.44 g, 3.15 mmol), and the mixture was stirred for 45 min
at rt. After completion of the reaction, the mixture was concen-
trated and extracted with diethyl ether, washed with water, and
brine. The organic layer was dried over Na2SO4 and concentrated.
The residue was purified by silica gel column chromatography (10%
ethyl acetate in hexane) gave 19 (0.53 g, 89%) as a colorless solid.
methanol in chloroform). [
a
]
þ3.4 (c 1.8, MeOH). IR (KBr): 3408,
D
3345e3200, 2922, 2854, 1652, 1468, 1257, 1190, 1070, 1044, 744,
621 cmꢁ1 1H NMR (300 MHz, CD3OD):
.
d
3.68 (m, 1H, CH-3),
3.26e3.22 (m,1H, CH-2),1.49e1.27 (m, 31H),1.20 (d, 3H, J¼6.7, CH3-
1), 0.89 (t, 3H, J¼6.2, CH3-18). 13C NMR (75 MHz, CDCl3):
d 75.0,
50.6, 32.7, 32.2, 30.1, 29.5, 26.3, 22.9, 17.1, 14.2. MS (ESI): m/z 287
[Mþ1]þ. Anal. Calcd for C18H39NO: C, 75.72; H, 13.77; N, 4.91.
Found: C, 75.77; H, 13.92; N, 5.11.
Mp: 69e72 ꢀC. Rf: 0.48 (20% ethyl acetate in hexane). [
a
]
25 þ0.23 (c
D
1.54, MeOH). IR (KBr): 3328, 2963, 2838, 1446, 963, 852, 718 cmꢁ1
.
Acknowledgements
1H NMR (300 MHz, CDCl3):
d 3.39e3.27 (m, 1H), 2.93e2.87 (m, 1H),
2.77e2.72 (m, 1H), 2.65e2.61 (m, 1H), 2.51e2.49 (m, 1H), 1.59e1.19
This research project was partly supported by DST and ICMR,
India. SAIF, CDRIy is acknowledged for analytical data. Subal and
Sajal thank CSIR for fellowships.
(m, 28H), 0.81 (t, 3H, J¼6.5). 13C NMR (75 MHz, CDCl3):
d 71.6, 55.4,
45.0, 34.0, 31.6, 29.6, 29.5, 29.3, 25.1, 22.6, 14.0. MS (ESI): m/z 285
[M]þ. Anal. Calcd for C18H36O2: C, 76.00; H, 12.76. Found: C, 76.09;
H, 12.83.
Supplementary data
4.1.16. (2R,3S)-1,2-Epoxy-3-methoxymethoxyocta-decane (20). From
19 (0.51 g,1.79 mmol), the title compound was prepared in the same
manner as that described for 9. Purification of the crude product by
silica gel column chromatography (10% ethyl acetate in hexane)
Supplementary data associated with this article can be found in
clude MOL files and InChIKeys of the most important compounds
described in this article.
afforded 20 (0.564 g, 96%) as a colorless oil. Rf: 0.5 (35% ethyl acetate
25
in hexane). [
a
]
þ18.4 (c 1.2, MeOH). IR (neat): 2917, 2843, 1408,
D
References and notes
1369, 1249, 1220, 1141, 1043, 724 cmꢁ1. 1H NMR (300 MHz, CDCl3):
d
4.88 (d, 1H, J¼6.6, OCHaHbO), 4.66 (d, 1H, J¼6.7, OCHaHbO), 3.40 (s,
1. Jares-Erijman, E. A.; Bapat, C. P.; Lithgow-Bertelloni, A.; Rinehart, K. L.; Sakai, R.
J. Org. Chem. 1993, 58, 5732.
2. Garrido, L.; Zubia, E.; Ortega, M. J.; Naranjo, S.; Salva, J. Tetrahedron 2001, 57,
3H, OCH3), 3.29e3.22 (m, 1H, H3), 3.00e2.96 (m, 1H, H2), 2.78 (t, 1H,
J¼4.6, CHaHb-1), 2.54e2.52 (m, 1H, CHaHb-1), 1.65e1.25 (m, 28H),
4579.
0.88 (t, 3H, J¼6.9). 13C NMR (75 MHz, CDCl3):
d 95.4, 78.0, 55.5, 54.7,
3. Aeillo, A.; Fattorusso, E.; Giordano, A.; Menna, M.; Navarrete, C.; Munoz, E.
Bioorg. Med. Chem. 2007, 15, 2920.
4. Kossuga, M. H.; MacMillan, J. B.; Rogers, E. W.; Molinski, T. F.; Nascimento, G. G. F.;
Rocha, R. M.; Berlinck, R. G. S. J. Nat. Prod. 2004, 67, 1879.
5. Cuadros, R.; Montejo de Garcini, E.; Wandosell, F.; Faircloth, G.; Fernandez-
Sousa, J. M.; Avila, J. Cancer Lett. 2000, 152, 23.
43.8, 32.3, 31.9, 29.67, 29.63, 29.62, 29.56, 29.51, 29.34, 25.4, 22.6,
14.1. MS (ESI): m/z 329 [M]þ. Anal. Calcd for C20H40O3: C, 73.12; H,
12.27. Found: C, 73.28; H, 12.46.
6. Sanchez, A. M.; Malagarie-Cazenave, S.; Olea, N.; Vara, D.; Cuevas, C.; Diaz-
Laviada, I. Eur. J. Pharmacol. 2008, 584, 237.
7. Singh, R.; Sharma, M.; Joshi, P.; Rawat, D. S. Anti-Cancer Agents Med. Chem. 2008,
8, 603.
4.1.17. (2R,3S)-3-Methoxymethoxyoctadecan-2-ol (21). From 20
(0.540 g, 1.64 mmol), the title compound was prepared in the same
manner as that described for 2. Purification of the crude product by
silica gel column chromatography (15% ethyl acetate in hexane)
afforded 21 (509 mg, 94%) as a colorless liquid. Rf: 0.41 (35% ethyl
8. (a) Prostenik, M.; Alaupovic, P. Croat. Chem. Acta 1957, 29, 393; (b) Yun, J. M.;
Sim, T. B.; Hahm, H. S.; Lee, W. K.; Ha, H.-J. J. Org. Chem. 2003, 68, 7675; (c)
Allepuz, A. C.; Badorrey, R.; Diaz-de-Villegas, M. D.; Galvez, J. A. Eur. J. Org. Chem.
2009, 6172; (d) Seguin, C.; Ferreira, F.; Botuha, C.; Chemla, F.; Perez-Luna, A. J.
Org. Chem. 2009, 74, 6986; (e) Amarante, G. W.; Cavallaro, M.; Coelho, F. Tet-
rahedron Lett. 2010, 51, 2597; (f) Ghosal, P.; Shaw, A. K. Tetrahedron Lett. 2010, 51,
4140.
9. (a) U.S. Patent 6,107,520, 2000. (b) European patent PCT/GB2001/002487, 2007.
10. Kolb, H. C.; VanNieuwenhze, M. S.; Sharpless, K. B. Chem. Rev. 1994, 94, 2483.
11. For ‘buffered’ AD reaction of allylic chlorides, see: Vanhessche, K. P. M.; Wang,
Z.-M.; Sharpless, K. B. Tetrahedron Lett. 1994, 35, 3469.
acetate in hexane). [
a]
25 þ17.3 (c 1.3, MeOH). IR (neat): 3443, 2913,
D
2839, 1461, 1244, 1204, 1140, 1028, 913, 712 cmꢁ1
.
1H NMR
(300 MHz, CDCl3):
d 4.74e4.68 (m, 2H), 3.73e3.65 (m, 1H), 3.42 (s,
3H), 3.29e3.23 (m, 1H), 3.04 (br s, 1H), 1.59e1.25 (m, 28H), 1.15 (d,
3H, J¼6.3), 0.88 (t, 3H, J¼6.3). 13C NMR (75 MHz, CDCl3):
d 97.3, 85.4,
69.2, 55.7, 31.9, 31.1, 29.8, 29.6, 29.3, 25.0, 22.6, 19.0, 14.0. MS (ESI):
m/z 331 [M]þ. Anal. Calcd for C20H42O3: C, 72.67; H, 12.81. Found: C,
72.81; H, 12.94.
12. Zhang, Z.-B.; Wing, Z.-M.; Wang, Y.-X.; Liu, H.-Q.; Lei, G.-X.; Shi, M. J. Chem. Soc.,
Perkin Trans. 1 2000, 532.
13. For a recent review on protecting group-free total synthesis, see: Young, I. S.;
Baran, P. S. Nat. Chem. 2009, 1, 193.
4.1.18. (2S,3S)-2-Azido-3-methoxymethoxyoctadecane
(22). From
14. Sasaki, M.; Tanino, K.; Hirai, A.; Miyashita, M. Org. Lett. 2003, 5, 1789.
15. (a) Rogers, E. W.; Molinski, T. F. J. Org. Chem. 2009, 74, 7660; (b) Hayes, C. J.;
Sherlock, A. E.; Selby, M. D. Org. Biomol. Chem. 2006, 4, 193.
16. Katsuki, T.; Sharpless, K. B. J. Am. Chem. Soc. 1980, 102, 5974.
17. (a) Caron, M.; Carlier, P. R.; Sharpless, K. B. J. Org. Chem. 1988, 53, 5185; (b)
Behrens, C. H.; Sharpless, K. B. J. Org. Chem. 1985, 50, 5696; (c) Caron, M.;
Sharpless, K. B. J. Org. Chem. 1985, 50, 1557.
18. (a) Calvani, F.; Crotti, P.; Gardelli, C.; Pineschi, M. Tetrahedron 1994, 50, 12999;
(b) Chini, M.; Crotti, P.; Gardelli, C.; Macchia, F. J. Org. Chem. 1994, 59, 4131.
19. He, L.; Byun, H.-S.; Bittman, R. J. Org. Chem. 2000, 65, 7618.
20. Roush, W. R.; Adam, M. A. J. Org. Chem. 1985, 50, 3752.
21 (410 mg, 1.24 mmol), the title compound was prepared in the
same manner as that described for 10. Purification of the crude
product by silica gel column chromatography (4% ethyl acetate in
hexane) afforded 22 (313 mg, 71%) as a colorless liquid. Rf: 0.58 (10%
25
ethyl acetate in hexane). [
(300 MHz, CDCl3):
a
]
þ11.3 (c 1.7, MeOH). 1H NMR
D
d 4.73e4.64 (m, 2H), 3.62e3.51 (m, 2H), 3.39 (s,
3H), 1.61e1.19 (m, 31H), 0.86 (t, 3H, J¼6.9). 13C NMR (75 MHz,
CDCl3): d 96.4, 80.3, 59.6, 55.6, 31.8, 30.4, 29.62, 29.60, 29.52, 29.48,
29.3, 25.4, 22.6, 14.2, 14.0. MS (ESI): m/z 356 [M]þ, 342 [MꢁN2]þ.
y
CDRI communication number 7355.